4Sturgeon CM, Ellis AR. Standardization of FSH, LH and hCG-current position and future prospects[J]. Mol Cell Endocrinol, 2007,260-262 : 301-309. 被引量：1
5Shaw J E,Sicree R A,Zimmet P Z.Global estimates of the prevalence of diabetes for 2010 and 2030.Diabetes Res Clin Pract,2010,87(1):4-14. 被引量：1
6Banting F G,Best C H,Collip J B.Pancreatic extracts in the treatment of diabetes mellitus.Can Med Assoc J,1922,12 (3):141-146. 被引量：1
7Yalow R S,Berson S A.Immunoassay of endogenous plasma insulin in man.J Clin Invest,1960,39:1157-1175. 被引量：1
8Grasbeck R,Saris N E.Establishment and use of normal values.Scand J Clin Lab Invest,1969,26 (Suppl 110):62-63. 被引量：1
9International Federation of Clinical Chemistry (IFCC),Clinical Laboratory and Standards Institute.Defining,Establishing,and Verifying Reference Intervals in the Clinical Laboratory.Proposed Guideline.3rd ed.CLSI document C28-P3,2008. 被引量：1
